Tianeptine: Phase IIa started

Revive began a double-blind, placebo-controlled, crossover, Dutch Phase IIa trial to evaluate oral REV-001 in 16 healthy volunteers receiving infusions of alfentanil. The first dose cohort of 8 patien...